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1 Approximation of cumulative distribution function
The cumulative distribution function is an integral function that can be numerically calculated
using integrals; however, this can consume time during simulations, therefore for applications
where extreme accuracies are not necessary (such as here, because the experimental inaccuracy
would be greater anyway), the function is approximated using a mathematical formula that is
very quickly computed by the simulator.
The cumulative distribution function, also called error function:
ΓG (CE) =
1
σE
√
2 pi
∫ CE
CE,min
e−(CE−CE, thr)
2
/(2·σ2E)dCE (1)
ΓM (CB) =
1
σB
√
2 pi
∫ CB
CB,min
e−(CB−CB, thr)
2
/(2·σ2B)dCB (2)
is approximated using Press’ method 1, with x being a normally distributed variable with a
mean of 0 and a standard deviation equal to 1:
erf(x) =
{
1− τ for x> 0
τ−1 for x < 0
(3)
where:
τ = t · exp(−x2−1.26551223+1.00002368 · t +0.37409196 · t2
+0.09678418 · t3−0.18628806 · t4 +0.27886807 · t5
−1.13520398 · t6 +1.48851587 · t7−0.82215223 · t8 +0.17087277 · t9)
(4)
and
t =
1
1+0.5 · |x| (5)
CB,b and CE,e are converted to standard normally distributed variables as follows:
xE,e =
CE,e−CE, thr
σE
∀ e ∈ {0, ..., nE} (6)
1Press WH, Flannery BP, Teukolsky SA, Vetterling WT (1992), Numerical Recipes in Fortran 77: The Art of
Scientific Computing (Cambridge University Press) pp. 214.
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Figure S1: Analysing the number of discretisation intervals needed by the PBM is useful to define
the most computationally efficient conditions satisfying the required resolution in the variables. (A)
Evolution of cell loss with decreasing number of intervals in each phase (Total %: percentage of total
cells remaining after 1000h, G lost %: percentage of total cells that were lost on the last bin of G0/G1
(cumulative), M lost %: percentage of total cells that were lost on the last bin of G2/M (cumulative)). (B)
Changes in Cyclin B expression patterns with increase in bin numbers (Smoothed: nB=5; Unsmoothed:
nB=60; Undersmoothed: nB=200). Examples for K-562 under even phase distribution conditions
and
xB,b =
CB,b−CB, thr
σB
∀ b ∈ {0, ..., nB} (7)
xE,e or xB,b can be replaced in equations 4 and 5 and the resulting erf(xE,e) or erf(xB,b) can
be calculated.
2 Derivation of the even phase distribution equations
Even phase distributions occur when cells are asynchronously moving from phase to phase,
which over time leads to a steady state in the phase distributions. A steady state is defined by
the absence of change in a variable over time. Mathematically, it is achieved by setting the
derivative (change) of the particular variable to zero and calculating its constant value. Below
are the calculations for the PBM case.
Let us assume the model reaches steady-state (a situation found when the cell cycle distri-
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Figure S2: K-562, MEC-1 cells in each co-culture experiment (circles and diamonds: experimental
results; lines: model output). Results are shown after adjustment of kinetic parameters in co-culture.
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Figure S3: Representing the co-culture contents in a ternary plot allows the use of one (the Euclidean
distance) vs two (two of the cell line percentages) goodness of fit indicators. In this case, we apply this
strategy to define which of the six scenarios is closest to model predictions: e
xample of a model calculation for all 6 scenarios combining 10%/30%/60% mixtures (co-
culture T6). Points denote experimental values arranged for that particular scenario, while
dashed lines represent the simulation profile starting from each of the initial 6 scenario.
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bution is constant). It follows that:
dGe,%
dt
=−rG ·Ge,% + rG ·Ge−1,%− rG→S,e ·Ge,% = 0 ∀ e ∈ {2, . . . , nE} (8)
dSd,%
dt
=−rS ·Sd,% + rS ·Sd−1,% = 0 ∀ d ∈ {2, . . . , nD} (9)
dMb,%
dt
=−rM ·Mb,% + rM ·Gb−1,%− rM→G,b ·Mb,% = 0 ∀ b ∈ {2, . . . , nB} (10)
Reorganizing:
Ge,% =
rG ·Ge−1,%
rG→S,e + rG
= (1−ΓG,e) ·Ge−1,% ∀ e ∈ {2, ..., nE} (11)
Sd,% = Sd−1,% ∀ d ∈ {2, ..., nD} (12)
Mb,% =
rM ·Mb−1,%
rM→G,b + rM
= (1−ΓM,b) ·Mb−1,% ∀ b ∈ {2, ..., nB} (13)
Summing across all populations:
nE
∑
e′=1
Ge′,% =
(
nE
∑
e′=2
e′
∏
e′′=2
(1−ΓG,e′′)
)
·G1,% +G1,% (14)
nD
∑
d′=1
Sd′ = nD ·S1,% (15)
nB
∑
b′=1
Mb′,% =
(
nB
∑
b′=2
b′
∏
b′′=2
(1−ΓM,b′′)
)
·M1,% +M1,% (16)
Since ΓG,1 = 0 and ΓM,1 = 0:
nE
∑
e′=1
Ge′,% =
(
nE
∑
e′=1
e′
∏
e′′=1
(1−ΓG,e′′)
)
·G1,% (17)
nB
∑
b′=1
Mb′,% =
(
nB
∑
b′=1
b′
∏
b′′=1
(1−ΓM,b′′)
)
·M1,% (18)
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Table S1: Real cell line contents of blind tests
K-562 MEC-1 MOLT-4
T1 20% 40% 40%
T2 17% 17% 66%
T3 50% 0% 50%
T4 0% 20% 80%
T5 10% 90% 0%
T6 10% 30% 60%
T7 80% 10% 10%
T8 60% 40% 0%
T9 20% 50% 30%
Reorganizing:
G1,%
∑nEe′=1 Ge′,%
=
1(
∑nEe′=1∏
e′
e′′=1 (1−ΓG,e′′)
) (19)
S1,%
∑nDd′=1 Sd′
=
1
nD
(20)
M1,%
∑nBb′=1 Gb′,%
=
1(
∑nBb′=1∏
b′
b′′=1 (1−ΓM,b′′)
) (21)
Using equations 11– 13 we finally obtain the percentage of cells in each bin among all cells in
the phase:
Ge
∑nEe′=1 Ge′
=
∏ee′=1 (1−ΓG,e′)
∑nEe′=1∏
e′
e′′=1 (1−ΓG,e′′)
∀e ∈ {1, . . . , nE} (22)
Sd
∑nDd′=1 Sd′
=
1
nD
∀d ∈ {1, . . . , nD} (23)
Mb
∑nBb′=1 Mb′
=
∏bb′=1 (1−ΓM,b′)
∑nBb′=1∏
b′
b′′=1 (1−ΓM,b′′)
∀b ∈ {1, . . . , nB} (24)
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3 Cell cycle oscillations and cyclin concentration
Experimentally, the fluorescence of thousands of single cells are recorded using flow-cytometry.
This data has to be gathered in a significant manner by aggregating the fluorescences of all cells
and applying statistical analyses to derive significant information. As a downside, if an event is
very fast in time, it is very unlikely that many cells will be found at that stage, and as a result,
the behaviour during that short period of time will be lost in the global behaviour of the rest of
the population. In the next paragraph, we explain how this occurs with cyclin expression and
the impact it has on the experimental results (vs the model output).
Oscillations in cyclin concentration appear when the period of oscillation (the phase time) is
larger than both the sampling frequency and the dispersion in the phase. In the case of cyclin
E, since G1 phase represents a substantial portion of the total cell cycle time, oscillations were
more evident. However, due to a generally shorter G2/M phase, the oscillations for cyclin B
can only be seen in the beginning, when the EdU− population was more narrowly distributed.
For instance, a cell line with a faster G2/M phase, such as MOLT-4, will only reveal the cyclin
B peak at the very beginning, while K-562, which has much slower G2/M kinetics, displays
the whole cyclin B trajectory. Cyclin concentration, both in vitro and in silico, is the result of
population-wide averaging (geometric mean). If two different populations appear in the same
phase, an averaged cyclin concentration level is reached, which might not be representative of
any of the two. This was the case for cyclin B in K-562 cells (Figure 4 in the manuscript)
4 Table of variables
A table of variables is required to define all the terms used in the equations, their significance
and the corresponding units.
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Table S2: Definitions
Symbol Description Units Source
Cell Lines
K562 Chronic Myeloid Leukemia; ATCC Cat. #CCL243
MEC1 B-Cell Chronic Lymphocytic Leukemia; DSMZ Cat. #ACC495
MOLT4 Acute Lymphocytic Leukemia; ATCC Cat. #CRL1582
Cell Cycle Phases
G Aggregated phase including G0 (resting) & G1 (growth preparing for DNA
synthesis) phases
S Synthesis phase; cells replicate their DNA
M Aggregated phase incorporating G2 (growth preparing for mitosis) & M (mitosis)
phases
State Variables
CB Cyclin B; Increased expression during G2 phase normalized cyclin
CE Cyclin E; Increased expression during G1 → S transition normalized cyclin
DNA Deoxyribonucleic acid; Doubles during S phase [copies]
t Time [hr]
Measurable Model
Parameters
CE,min Minimum value of cyclin E
CB,min Minimum value of cyclin B
CE, thr Transition threshold of cyclin E
CB, thr Transition threshold of cyclin B
CE,max Maximum value of cyclin E
CB,max Maximum value of cyclin B
G0 Initial cellular fraction in G [–]
S0 Initial cellular fraction in S [–]
M0 Initial cellular fraction in M [–]
S0,1 Fraction of S phase cells in first quarter of S phase [–]
S0,2 Fraction of S phase cells in second quarter of S phase [–]
S0,3 Fraction of S phase cells in third quarter of S phase [–]
S0,4 Fraction of S phase cells in last quarter of S phase [–]
σ Standard deviation of cyclin distribution
TG Cell cycle time in G phase [hr]
TS Cell cycle time in S phase [hr]
TM Cell cycle time in M phase [hr]
Derived Model
Parameters
rG dCE/dt; Increasing rate of CE expression during G phase [normalized cyclin/ hr] Eq 4
rS dDNA/dt; Increasing rate of DNA during S phase [copies / hr] Eq 5
rM dCB/dt; Increasing rate of CB expression during M phase [normalized cyclin/ hr] Eq 6
rG→S (CE ) Transition rate from G to S phase [normalized cyclin/ hr] Eq 1
rM→G (CB) Transition rate from M to G phase [normalized cyclin/ hr] Eq 3
ΓG (CE ) Probability distribution for transition according to cyclin levels in G [–] Eq 7
ΓM (CB) Probability distribution for transition according to cyclin levels in M [–] Eq 8
Discretised Model
Parameters
nE Number of bins in the G phase
nD Number of bins in the S phase
nB Number of bins in the M phase
Ge Cells in the eth bin of G; e ∈ {1, . . . , nE}
Sd Cells in the dth bin of S; d ∈ {1, . . . , nD}
Mb Cells in the bth bin of M; b ∈ {1, . . . , nB}
νE Cyclin E to bin width conversion factor [–] Eq 12
νD DNA to bin width conversion factor [–] Eq 13
νB Cyclin B to bin width conversion factor [–] Eq 14
rG→S,e Transition rate from G to S phase [normalized cyclin/ hr] Eq 18
rM→G,b Transition rate from M to G phase [normalized cyclin/ hr] Eq 20
ΓG,e Probability distribution for transition according to cyclin levels in G [–]
ΓM,b Probability distribution for transition according to cyclin levels in M [–]
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Figure S4: Flow cytometry plots of co-cultures. All axes are expressed in fluorescence intensity. SSC
accounts for cellular complexity; DNA appears as a more pronounced group on the left (G1 phase
cells), a continuous shade (S phase cells) leading to a second, smaller group on the right (G2/M phase
cells); CD19 is a MEC-1 specific marker. The plots shown above are the ones used to determine the
percentages of each cell line in co-culture, according to the different patterns in CD19, SSC, CycB and
DNA displayed by each of them. Regions where a particular cell line is identified are shown along with
the corresponding percentage. (A) FITC CD19 vs SSC plot of a K-562, MEC-1 and MOLT-4 mixture
- CD19 positive region identified based on a separate MEC-1 single culture and then applied to the
co-culture plot to obtain the MEC-1 percents; (B) FITC Cyclin B vs DNA plot of a K-562, MEC-1 and
MOLT-4 mixture - MOLT-4 region identified based on a separate Cyclin B vs DNA plot of MOLT-4
single culture; (C) DNA vs SSC plot of a K-562 and MOLT-4 mixture - K-562 and MOLT-4 regions
defined based on single cultures.
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Figure S5: Comparison of calculation paths for processing flow-cytometry and mathematical data to
obtain the same geometric mean of cyclin parameter (example case for G0/G1 phase and cyclin E).
In flow-cytometry, the individual fluorescences of cells are multiplied and the nth root of the product is
calculated (n being the total number of cells). In the PBM, the cyclin values in each bin (Ce) to the power
of the number of cells in that bin (Ge) are multiplied, and then the nthroot of the whole is calculated (n
being the sum of cells in all bins).
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5 Table of parameters
A table of parameters is required to define which entities are given experimentally and what
values they take.
Table S3: Measured Parameter Values
K-562 MEC-1 MOLT-4
CE,min (%) 10 10 0
CB,min (%) 22 20 60
CE, thr (%) 50 30 80
CB, thr (%) 180 135 125
GEdU−,0,% (%) 69 74 66
SEdU−,0,% (%) 9 14 31
MEdU−,0,% (%) 22 12 3
S0,1 (% over S) 20 42 67
S0,2 (% over S) 44 4.8 10
S0,3 (% over S) 32 4.2 8
S0,4 (% over S) 4 35.9 14
TG (h) 9 8.5 12
TS (h) 10 7.5 15
TM (h) 5 3 2
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6 Summary of PBM variables and parameters
The following measured and derived parameters are required to run the discretised PBM:
• nE ×CE levels, nB×CB levels and nD×DNA levels (derived)
• nE ×ΓCE,e and nB×ΓCB,b transition probabilities (derived)
• nE × rG→S,e and nB× rM→G,b transition rate coefficients (derived)
• growth rates rG, rS and rM (derived)
• discretisation factors νE , νD and νB (derived)
• initial conditions GEdU−,0,%, SEdU−,0,% and MEdU−,0,% (measured)
• cyclin minima CE,min and CB,min (measured)
• cyclin thresholds CE, thr and CB, thr (measured)
• cyclin maxima CE,max and CB,max (derived)
• cell cycle phase durations TG, TS and TM (measured)
• intra S phase distributions S0,1, S0,2 and S0,3 (measured)
• transition variabilities σE and σB (theoretically measured, but not significant according
to GSA)
The following variables are calculated when running the discretized PBM:
• nE ×Ge, nB×Mb, nD×Sd and T cell numbers
• nE ×Ge,%, nB×Mb,% and nD×Sd,% phase percentages
• geometric mean of cyclin E and B: GeomE and GeomB
Since we have set nE = 60, nD = 20 and nB = 60, the total number of measured and derived
parameters is 400 and the total number of variables is 283.
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7 Co-culture assumptions
Table S4: Co-culture parameter values
Co-culture # K-562 MEC-1 MOLT-4
CE,min (%) 10 10 0
CB,min (%) 22 20 60
CE, thr (%) 50 30 80
CB, thr (%) 180 135 125
TG (h) 9 12.1 12
TS (h) 10 10.7 15
TM (h) 5 4.3 2
T1 18 30 52
T2 10 17 73
T3 40 0 60
T4 0 12 88
Measured cell line % T5 31 69 0
T6 13 17 70
T7 81 6 13
T8 64 36 0
T9 15 38 47
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